Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Waldenstrom's Macroglobulinemia Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for qualified healthcare advice, visits or treatment by using a genuine mD. We are not doctors. Always consult your doctor about Waldenstrom's Macroglobulinemia conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Waldenstrom's Macroglobulinemia Clinical research trials and Waldenstrom's Macroglobulinemia health trials occur in many of cities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new drugs. The intent of the studies / projects is to figure out particular human health questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate treatments for all forms of circumstances, such as Waldenstrom's Macroglobulinemia. Waldenstrom's Macroglobulinemia Clinical Trials and other clinical trials allow volunteers to access healthcare treatment choices before they are available to the general public. Most times the participants undergo treatment for without cost, and occasionally they are compensated for their time. Sometimes there is a cost for a Waldenstrom's Macroglobulinemia clinical trial. Human subjects oftentimes obtain the finest healthcare possible for their Waldenstrom's Macroglobulinemia affliction. Risks are a reality, nevertheless, and may include additional or frequent dr. visits, health dangers (potentially life-jeopardising), and/or the treatment being uneffective. Trials are federally regulated with rigorous guidelines to protect clinical trials subjects.

Home > Clinical Trials by Conditions > "W" Clinical Trial Conditions > Waldenstrom's Macroglobulinemia Clinical Trials

Waldenstrom's Macroglobulinemia Clinical Trials



506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
Condition: mount_sinai_medical_center_clinical_trials.html
Mount Sinai Medical Center

Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: lifetime_pharmaceuticals_clinical_trials.html
LifeTime Pharmaceuticals

BMS-247550 in Treating Patients With Relapsed or Refractory Low-Grade Lymphoproliferative Disorders
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Bone Marrow Transplantation in Treating Patients With Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Condition: massey_cancer_center_clinical_trials.html
Massey Cancer Center

Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Condition: ireland_cancer_center_clinical_trials.html
Ireland Cancer Center

Bortezomib in Treating Patients With Lymphoproliferative Disorders
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Combination Chemotherapy and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: theradex_clinical_trials.html
Theradex

Comparison of Fludarabine Plus Total-body Irradiation With Combination Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Condition: simmons_cancer_center_clinical_trials.html
Simmons Cancer Center

Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

FR901228 in Treating Patients With Hematologic Cancer
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Interferon alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non- Hodgkin's Lymphoma
Condition: groupe_detudes_de_lymphomes_de_ladulte_clinical_trials.html
Groupe d'Etudes de Lymphomes de L'Adulte

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Condition: sidney_kimmel_cancer_center_clinical_trials.html
Sidney Kimmel Cancer Center

Monoclonal Antibody Therapy in Treating Patients With Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
Condition: garden_state_cancer_center_clinical_trials.html
Garden State Cancer Center

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
Condition: eastern_cooperative_oncology_group_clinical_trials.html
Eastern Cooperative Oncology Group

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Rituximab With or Without Interleukin-12 in Treating Patients With Non-Hodgkin's Lymphoma
Condition: north_central_cancer_treatment_group_clinical_trials.html
North Central Cancer Treatment Group

Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder
Condition: aids_associated_malignancies_clinical_trials_consortium_clinical_trials.html
AIDS Associated Malignancies Clinical Trials Consortium

Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center



Waldenstrom's Macroglobulinemia Clinical Trials

Modify your Search

Waldenstrom's Macroglobulinemia Clinical Trials by State:

Alabama
Arizona
California
Colorado
Delaware
District Of Columbia
Florida
Georgia
Illinois
Indiana
Iowa
Kansas
Louisiana
Maryland
Massachusetts
Michigan
Minnesota
Missouri
Nebraska
Nevada
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
South Dakota
Tennessee
Texas
Virginia
Wisconsin

Other "W" Clinical Trials Conditions:

Waldenstrom Macroglobulinemia
Waldenstrom's Macroglobulinemia
Wasting Disease
Wegener's Granulomatosis
Weight Changes
Weight Gain
Weight Loss
Werner's Syndrome
West Nile Fever
West Nile Virus
Whiplash Injuries
Whooping Cough
Williams Syndrome
Wilms' Tumor
Wilms' Tumor And Other Childhood Kidney Tumors
Wilson Disease
Wiskott-Aldrich Syndrome
Wolman Disease
Wound Healing
Wound Infections
Wounds And Injuries


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103